Global Liquid Biopsy Market - Analysis and Forecast, 2017-2025

(Focus on Product Type, Therapeutic Application, End User, Market Share Analysis, Country Analysis, and Competitive Landscape)

Published Year: 2017
SKU: BH00530SA
View TOC Request Sample

4599

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Report Description

With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an imp

Read More

Key Questions Answered in this Report

What are the major market drivers, challenges, and opportunities in the global liquid biopsy market?

Read More

Market Overview

With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an imp

Read More

Table of Contents

Request a Sample

Report Scope & Methodology

1.1 Scope of the Report
1.2 Market segmentation 
1.3 Research Methodology
1.3.1 Data Triangulation
1.3.2 Key Data Points From Primary Sources 
1.3.3 Key Data Points From Secondary Sources 
1.3.4 Secondary Data Sources
1.3.5 Top-Down  Approach (Segmental Analysis)
1.3.6 Bottom-Up Approach (Segmental Analysis)
1.4 Assumptions and Limitations
1.5 Data and Prediction Modelling

Market Overview

2.1 Introduction
2.2 Overview of Liquid Biopsy Techniques and Applications
2.3 Historical trends
2.4 Comparative Analysis of Tissue Biopsy and Liquid Biopsy

Market Dynamics

3.1 Promoting and Inhibiting Factors of Liquid Biopsy Market Growth
3.2 Drivers
3.3 Restraints
3.4 Opportunities

Competitive Insights

4.1 Share of Key Development and  Strategies
4.2 Competitive Landscape 
4.3 Market Share Analysis
4.4 Industry Attractiveness
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

Global Liquid Biopsy Market, by Product

5.1 Overview
5.2 Kits and Consumables
5.3 Instruments
5.4 Services

Global Liquid Biopsy Market, by Type of Biomarker

6.1 Overview
6.2 Circulating Tumor Cell (CTC)
6.3 Circulating Tumor DNA (ctDNA)
6.4 Extracellular Vesicles (EVs) 
6.5 Other Types of Biomarkers

Global Liquid Biopsy Market, by Cancer Type

7.1 Liquid Biopsy's Role in Cancer Detection: An Overview
7.2 Liquid Biopsy: Role in Lung Cancer Diagnosis
7.3 Liquid Biopsy: Role in Breast Cancer Diagnosis 
7.4 Liquid Biopsy: Role in Colorectal Cancer Diagnosis
7.5 Liquid Biopsy: Role in Prostate Cancer Diagnosis
7.6 Liquid Biopsy: Role in Liver Cancer Diagnosis
7.7 Liquid Biopsy: Role in Other Cancer Diagnosis

Global Liquid Biopsy Market, by End User

8.1 Overview
8.2 Reference Laboratories
8.3 Hospitals and Physician Laboratories
8.4 Academic and Research Centers
8.5 Other End Users

Global Liquid Biopsy Market, by Geography

9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of the Asia Pacific
9.5 Rest of the World

Company Profile

10.1 Adaptive Biotechnologies
10.1.1 Overview
10.1.2 Adaptive Biotechnologies: Corporate Summary
10.1.3 Adaptive Biotechnologies: SWOT Analysis
10.2 ANGLE plc     
10.2.1 Overview
10.2.2 Financials
10.2.2.1 Financial Summary
10.2.3 ANGLE plc: SWOT Analysis
10.3 Biocept, Inc.
10.3.1 Overview
10.3.2 Financials
10.3.2.1 Financial Summary
10.3.3 Biocept, Inc.: SWOT Analysis
10.4 Bio-Rad Laboratories, Inc.
10.4.1 Overview
10.4.2 Bio-Rad Laboratories, Inc.: Product Portfolio
10.4.3 Financials
10.4.3.1 Financial Summary
10.4.4 Bio-Rad Laboratories, Inc.: SWOT Analysis
10.5 CareDx, Inc.
10.5.1 Overview
10.5.2 Financials
10.5.2.1 Financial Summary
10.5.3 CareDx, Inc.: SWOT Analysis
10.6 Cynvenio Biosystems, Inc.
10.6.1 Overview
10.6.2 Cynvenio Biosystems, Inc.: Product Portfolio
10.6.3 Corporate Summary
10.6.4 Cynvenio Biosystems, Inc.: SWOT Analysis
10.7 Epic Sciences, Inc.
10.7.1 Overview
10.7.2 Epic Sciences, Inc.: Corporate Summary
10.7.3 Epic Sciences, Inc.: SWOT Analysis
10.8 F. Hoffmann-La Roche AG
10.8.1 Overview
10.8.2 F. Hoffmann-La Roche AG: Product Portfolio
10.8.3 Financials
10.8.3.1 Financial Summary
10.8.4 F. Hoffmann-La Roche AG: SWOT Analysis
10.9 Genomic Health, Inc.
10.9.1 Overview
10.9.2 Genomic Health, Inc.: Product Portfolio
10.9.3 Financials
10.9.3.1 Financial Summary
10.9.4 Genomic Health, Inc.: SWOT Analysis
10.10 GUARDANT HEALTH, INC
10.10.1 Overview
10.10.2 GUARDANT HEALTH, INC: Corporate Summary
10.10.3 GUARDANT HEALTH, INC: SWOT Analysis
10.11 Illumina, Inc.
10.11.1 Overview
10.11.2 Illumina, Inc.: Product Portfolio
10.11.3 Financials
10.11.3.1 Financial Summary
10.11.4 Illumina, Inc.: SWOT Analysis
10.12 JOHNSON & JOHNSON
10.12.1 Overview
10.12.2 JOHNSON & JOHNSON: Product Portfolio
10.12.3 Financials
10.12.3.1 Financial Summary
10.12.4 JOHNSON & JOHNSON: SWOT Analysis
10.13 MDxHealth, Inc.
10.13.1 Overview
10.13.2 Financials
10.13.2.1 Financial Summary
10.13.3 MDxHealth, Inc.: SWOT Analysis
10.14 Menarini Silicon Biosystems, Inc.
10.14.1 Overview
10.14.2 Menarini Silicon Biosystems, Inc.: Product Portfolio
10.14.3 Corporate Summary
10.14.4 Menarini Silicon Biosystems, Inc.: SWOT Analysis
10.15 Myriad Genetics, Inc.
10.15.1 Overview
10.15.2 Myriad Genetics, Inc.: Product Portfolio
10.15.3 Financials
10.15.3.1 Financial Summary
10.15.4 Myriad Genetics, Inc.: SWOT Analysis
10.16 Natera, Inc.
10.16.1 Overview
10.16.2 Natera, Inc.: Product Portfolio
10.16.3 Financials
10.16.3.1 Financial Summary
10.16.4 Natera, Inc.: SWOT Analysis
10.17 NeoGenomics Laboratories, Inc.
10.17.1 Overview
10.17.2 NeoGenomics Laboratories, Inc.: Product Portfolio
10.17.3 Financials
10.17.3.1 Financial Summary
10.17.4 NeoGenomics Laboratories, Inc.: SWOT Analysis
10.18 QIAGEN
10.18.1 Overview
10.18.2 QIAGEN: Product Portfolio
10.18.3 Financials
10.18.3.1 Financial Summary
10.18.4 QIAGEN: SWOT Analysis
10.19 RainDance Technologies, Inc.
10.19.1 Overview
10.19.2 RainDance Technologies, Inc.: Product Portfolio
10.19.3 Financials
10.19.3.1 Financial Summary
10.19.4 RainDance Technologies, Inc.: SWOT Analysis
10.20 Sysmex Corporation
10.20.1 Overview
10.20.2 Sysmex Corporation: Product Portfolio
10.20.3 Financials
10.20.3.1 Financial Summary
10.20.4 Sysmex Corporation: SWOT Analysis
10.21 Thermo Fisher Scientific
10.21.1 Overview
10.21.2 Thermo Fisher Scientific: Product Portfolio
10.21.3 Financials
10.21.3.1 Financial Summary
10.21.4 Thermo Fisher Scientific: SWOT Analysis
10.22 TROVAGENE, INC.
10.22.1 Overview
10.22.2 TROVAGENE, INC.: Product Portfolio
10.22.3 Financials
10.22.3.1 Financial Summary
10.22.4 TROVAGENE, INC.: SWOT Analysis

List of Tables

1 Cancer Incidence by Region, 2012 (Thousands)
2 Tissue Biopsy vs. Liquid Biopsy 
3 Joint Ventures, Partnerships, Agreements and Collaborations 
4 Product Launch
5 Mergers and Acquisitions
6 Regulatory Approval
7 Expansions and Others
8 List of Available Kits in the Market 
9 List of Available Instruments and Platforms in the Market 
10 List of Tests Available in the Market
11 Lung Cancer Incidence  in Top Countries (2014-2025)
12 Breast Cancer Incidence  in Top Countries (2014-2025)
13 Colorectal Cancer Incidence  in Top Countries (2014-2025)
14 Prostate Cancer Incidence  in Top Countries (2014-2025)
15 Liver Cancer Incidence in Top Countries (2014-2025)
16 Incidence Rate of Different Cancer Types, U.S. (2014-2025)
17 Incidence Rate of Different Cancer Types, Canada (2014-2025)
18 Incidence Rate of Different Cancer Types, U.K. (2014-2025)
19 Incidence Rate of Different Cancer Types, Germany (2014-2025)
20 Incidence Rate of Different Cancer Types, France (2014-2025)
21 Incidence Rate of Different Cancer Types, Italy (2014-2025)
22 Incidence Rate of Different Cancer Types, China (2014-2025)
23 Incidence Rate of Different Cancer Types, Japan (2014-2025)
24 Incidence Rate of Different Cancer Types, India (2014-2025)
25 Incidence Rate of Different Cancer Types, Australia (2014-2025)
26 Incidence Rate of Different Cancer Types, South Korea (2014-2025)
27 Incidence Rate of Different Cancer Types, Mexico (2014-2025)
28 Incidence Rate of Different Cancer Types, Turkey (2014-2025)
29 Incidence Rate of Different Cancer Types, Saudi Arabia (2014-2025)
30 Adaptive Biotechnologies: Overview
31 ANGLE plc: Overview
32 Biocept, Inc.: Overview
33 Bio-Rad Laboratories, Inc.: Overview
34 CareDx, Inc.: Overview
35 Cynvenio Biosystems, Inc.: Overview
36 Epic Sciences, Inc.: Overview
37 F. Hoffmann-La Roche AG: Overview
38 Genomic Health, Inc.: Overview
39 GUARDANT HEALTH, INC: Overview
40 Illumina, Inc.: Overview
41 JOHNSON & JOHNSON: Overview
42 MDxHealth, Inc.: Overview
43 Menarini Silicon Biosystems, Inc.: Overview
44 Myriad Genetics, Inc.: Overview
45 Natera, Inc.: Overview
46 NeoGenomics Laboratories, Inc.: Overview
47 QIAGEN: Overview
48 RainDance Technologies, Inc.: Overview
49 Sysmex Corporation: Overview
50 Thermo Fisher Scientific: Overview
51 TROVAGENE, INC.: Overview

List of Figures

1 Global Liquid Biopsy Market Revenue (2016-2025)
2 Global Liquid Biopsy Market Share, by Products and Services (2016)
3 Global Liquid Biopsy Market Share, by Products and Services (2025)
4 Global Liquid Biopsy Market Share, by Type of Biomarker (2016)
5 Global Liquid Biopsy Market Share, by Type of Biomarker (2025)
6 Global Liquid Biopsy Market Share, by Application (2016)
7 Global Liquid Biopsy Market Share, by Application (2025)
8 Global Liquid Biopsy Market Share, by End-User (2016)
9 Global Liquid Biopsy Market Share, by End-User (2025)
10 Liquid Biopsy Market Size, by Region
11 Liquid Biopsy Market Segmentation
12 Research Methodology
13 Evolution of Liquid Biopsy with Progress in Molecular Technologies and Biomarker Discovery 
14 Comparative Analysis of Tissue Biopsy and Liquid Biopsy
15 Share of Key Development and  Strategies
16 Market Share Analysis, by Companies (2015)
17 Market Share Analysis, by Companies (2016)
18 Porter’s Five Forces Analysis
19 Product Type Segmentation
20 Global Liquid Biopsy Market, by Product, 2016-2025 ($Million)
21 Global Liquid Biopsy Market Share, by Product, 2016-2025 
22 Global Liquid Biopsy Kits & Consumables Market, 2016-2025
23 Global Liquid Biopsy Instruments Market, 2016-2025 ($Million)
24 Global Liquid Biopsy Services Market, 2016-2025 ($Million)
25 Different Biomarkers  
26 Global Liquid Biopsy Market, by Biomarker Type, 2016-2025 ($Million)
27 Global liquid Biopsy Market, by Circulating Tumor Cells (CTCs), 2016-2025 ($Million)
28 List of Few CTC Based Kits and Instrument 
29 Global liquid Biopsy Market, by Circulating Tumor DNA (ctDNA), 2016-2025 ($Million)
30 List of Few ctDNA Based Kits and Instrument 
31 CTCs Vs ctDNA Analysis
32 Global liquid Biopsy Market, by Extracellular Vesicles (EVs), 2016-2025 ($Million)
33 Global liquid Biopsy Market, by Other Biomarkers (Cell Free DNA, etc.), 2016-2025 ($Million)
34 Standard Biopsy Vs Liquid Biopsy
35 Types of Lung Cancer
36 Lung Cancer Incidence Rate Statistics
37 List of Few Kits and Instruments for Lung Cancer Diagnosis 
38 Types of Breast cancer 
39 Breast Cancer  Incidence Statistics
40 List of Few Kits and Instruments for Breast Cancer Diagnosis
41 Infected Colon and Rectum
42 List of Few Kits and Instruments for Colorectal Cancer Diagnosis 
43 Colorectal Cancer Incidence Statistics
44 Prostate Cancer Incidence Statistics
45 List of Few Kits and Instruments for Prostate Cancer Diagnosis
46 Types of Liver Cancer
47 Liver Cancer Incidence Statistics
48 Global Liquid Biopsy Market Share, by End Users, 2016-2025
49 Global Liquid Biopsy Market, by End Users, 2016-2025 ($Million)
50 Global Liquid Biopsy End User Market, Reference Laboratories, 2016-2025 ($Million)
51 Global Liquid Biopsy End User Market, Hospitals and Physician Laboratories, 2016-2025 ($Million)
52 Global Liquid Biopsy End User Market, Academic and Research Centers, 2016-2025 ($Million)
53 Global Liquid Biopsy End User Market, Others, 2016-2025 ($Million)
54 Global Liquid Biopsy Market, by Region
55 Global Liquid Biopsy Market Revenue, by Region (2016-2025)
56 Global Liquid Biopsy Market Share, by Region (2016)
57 Global Liquid Biopsy Market Share, by Region (2025)
58 North America Liquid Biopsy Market Revenue (2016-2025)
59 North America Liquid Biopsy Market, by Products & Services (2016-2025)
60 North America Liquid Biopsy Market, by Country (2016-2025)
61 U.S. Liquid Biopsy Market Revenue (2016-2025) 
62 Canada Liquid Biopsy Market Revenue (2016-2025)
63 Europe Liquid Biopsy Market Revenue (2016-2025)
64 Europe Liquid Biopsy Market, by Products & Services (2016-2025)
65 Europe Liquid Biopsy Market, by Country (2016-2025)
66 U.K. Liquid Biopsy Market Revenue (2016-2025) 
67 Germany Liquid Biopsy Market Revenue (2016-2025)
68 France Liquid Biopsy Market Revenue (2016-2025)
69 Rest of Europe Liquid Biopsy Market Revenue (2016-2025)
70 Asia Pacific Liquid Biopsy Market Revenue (2016-2025)
71 Asia Pacific Liquid Biopsy Market, by Products & Services (2016-2025)
72 Asia Pacific Liquid Biopsy Market, by Country (2016-2025)
73 China Liquid Biopsy Market Revenue (2016-2025)
74 Japan Liquid Biopsy Market Revenue (2016-2025)
75 India Liquid Biopsy Market Revenue (2016-2025)
76 Rest of Asia Pacific Liquid Biopsy Market Revenue (2016-2025)
77 Rest of the World (RoW) Liquid Biopsy Market Revenue (2016-2025)
78 Adaptive Biotechnologies: SWOT Analysis
79 ANGLE plc: Overall Financials (2014-2016)
80 ANGLE plc: Revenue by Region
81 ANGLE plc: SWOT Analysis
82 Biocept, Inc.: Overall Financials (2014-2016)
83 Biocept, Inc.: SWOT Analysis
84 Bio-Rad Laboratories, Inc.: Product Mapping
85 Bio-Rad Laboratories, Inc.: Overall Financials (2014-2016)
86 Bio-Rad Laboratories, Inc.: Net Revenue by Business Segment (2014-2016)
87 Bio-Rad Laboratories, Inc.: Revenue by Region (2014-2016)
88 Bio-Rad Laboratories, Inc.: SWOT Analysis
89 CareDx: Overall Financials (2014-2016)
90 CareDx, Inc.: SWOT Analysis
91 Cynvenio Biosystems, Inc.: Product Mapping
92 Cynvenio Biosystems, Inc.: SWOT Analysis
93 Epic Sciences, Inc.: SWOT Analysis
94 F. Hoffmann-La Roche AG: Product Mapping
95 F. Hoffmann-La Roche AG: Overall Financials (2014-2016)
96 F. Hoffmann-La Roche AG: Revenue By Geographical Area (2014-2016)
97 F. Hoffmann-La Roche AG: Revenue by Division (2014-2016)
98 F. Hoffmann-La Roche AG: Revenue By Diagnostics Sub-Division (2014-2016)
99 F. Hoffmann-La Roche AG: SWOT Analysis
100 Genomic Health, Inc.: Product Mapping
101 Genomic Health, Inc.: Overall Financials (2014-2016)
102 Genomic Health, Inc.: Net Revenue by Region (2014-2016)
103 Genomic Health, Inc.: SWOT Analysis
104 GUARDANT HEALTH, INC: SWOT Analysis
105 Illumina, Inc: Product Mapping
106 Illumina, Inc.: Overall Financials (2014-2016)
107 Illumina, Inc.: Net Revenue by Business Segment (2014-2016)
108 Illumina, Inc.: Revenue by Region (2014-2016)
109 Illumina, Inc.: SWOT Analysis
110 JOHNSON & JOHNSON: Product Mapping
111 JOHNSON & JOHNSON: Overall Financials (2014-2016) 
112 JOHNSON & JOHNSON: Net Revenue by Business Segment (2014-2016)
113 JOHNSON & JOHNSON: Net Revenue by Region (2014-2016)
114 JOHNSON & JOHNSON: Net Revenue by Medical Devices Business Segment (2014-2016)
115 JOHNSON & JOHNSON: SWOT Analysis
116 MDxHealth, Inc.: Overall Financials (2014-2016)
117 MDxHealth, Inc.: SWOT Analysis
118 Menarini Silicon Biosystems, Inc.: Product Mapping
119 Menarini Silicon Biosystems, Inc.: SWOT Analysis
120 Myriad Genetics, Inc.: Product Mapping
121 Myriad Genetics, Inc.: Overall Financials (2014-2016)
122 Myriad Genetics, Inc.: Net Revenue by Business Segment (2014-2016)
123 Myriad Genetics, Inc.: SWOT Analysis
124 Natera, Inc.: Product Mapping
125 Natera, Inc.: Overall Financials (2014-2016)
126 Natera, Inc.: Net Revenue by Region (2014-2016)
127 Natera, Inc.: SWOT Analysis
128 NeoGenomics Laboratories, Inc.: Product Mapping
129 NeoGenomics Laboratories, Inc.: Overall Financials (2014-2016)
130 NeoGenomics Laboratories, Inc.: Net Revenue by Business Segment (2014-2016)
131 NeoGenomics Laboratories, Inc.: SWOT Analysis
132 QIAGEN: Product Mapping
133 QIAGEN: Overall Financials (2014-2016)
134 QIAGEN: Net Revenue by Region (2014-2016)
135 Qiagen: Revenue by Business Segments (2014-2016)
136 QIAGEN: SWOT Analysis
137 RainDance Technologies, Inc.: Product Mapping
138 RainDance Technologies, Inc.: Overall Financials (2014)
139 RainDance Technologies: Net Revenue by Region (2014)
140 RainDance Technologies, Inc.: SWOT Analysis
141 Sysmex Corporation: Product Mapping
142 Sysmex Corporation: Overall Financials (2014- 2016)
143 Sysmex Corporation: Revenue by Business Segment (2014-2016)
144 Sysmex Corporation: Revenue by Region(2014-2016)
145 Sysmex Corporation: SWOT Analysis
146 Thermo Fisher Scientific: Product Mapping
147 Thermo Fisher Scientific: Overall Financials (2014-2016)
148 Thermo Fisher Scientific: Net Revenue by Business Segment (2014-2016)
149 Thermo Fisher Scientific: Net Revenue by Region (2014-2016)
150 Thermo Fisher Scientific: SWOT Analysis
151 TROVAGENE, INC.: Product Mapping
152 TROVAGENE, INC.: Overall Financials (2014-2016)
153 TROVAGENE, INC.: SWOT Analysis

You may also like

Published Year: 2018

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Tests, Methods, Platforms, Applications

The global NIPT market is expected to reach $5.67 billion by...

 
Published Year: 2018

Global Liquid Biopsy Market: Focus on Products and Services, Therapeutic Applications, Clinical Appl

The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a...

 

Global Liquid Biopsy Market - Analysis and Forecast, 2017-2025

(Focus on Product Type, Therapeutic Application, End User, Market Share Analysis, Country Analysis, and Competitive Landscape)

Contact Us

Request a Sample Schedule a Call